Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA
RESEARCH TOOLSreports
Holding IPA?
Track your performance easily
IPA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.32 - $2.60
Previous Close$0.4
Volume192.81K
Average Volume (3M)554.37K
Market Cap
$13.05M
Enterprise Value$19.88M
Total Cash (Recent Filing)C$3.53M
Total Debt (Recent Filing)C$13.33M
Price to Earnings (P/E)―
Beta0.42
Next Earnings
Mar 12, 2025EPS Estimate
-$0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.75
Shares Outstanding27,300,000
10 Day Avg. Volume1,423,300
30 Day Avg. Volume554,365
Standard Deviation0.25
R-Squared0.00184
Alpha-0.00686
Financial Highlights & Ratios
Price to Book (P/B)0.33
Price to Sales (P/S)0.64
Price to Cash Flow (P/CF)-1.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$5.00Price Target Upside1149.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
ImmunoPrecise Antibodies News
PremiumCompany Announcements
ImmunoPrecise Antibodies to Showcase at Microcap Conference
PremiumCompany Announcements
ImmunoPrecise Antibodies Reports Mixed Financial Results
PremiumCompany Announcements
ImmunoPrecise Antibodies to Announce Q1 Financial ResultsOwnership Overview
7.73% Insiders
0.06% Mutual Funds
5.29% Other Institutional Investors
86.93% Public Companies and
Individual Investors
IPA FAQ
What was ImmunoPrecise Antibodies’s price range in the past 12 months?
ImmunoPrecise Antibodies lowest stock price was $0.32 and its highest was $2.60 in the past 12 months.
What is ImmunoPrecise Antibodies’s market cap?
Currently, no data Available
When is ImmunoPrecise Antibodies’s upcoming earnings report date?
ImmunoPrecise Antibodies’s upcoming earnings report date is Mar 12, 2025 which is in 80 days.
How were ImmunoPrecise Antibodies’s earnings last quarter?
ImmunoPrecise Antibodies released its earnings results on Dec 10, 2024. The company reported -$0.062 earnings per share for the quarter, beating the consensus estimate of -$0.066 by $0.003.
Is ImmunoPrecise Antibodies overvalued?
According to Wall Street analysts ImmunoPrecise Antibodies’s price is currently Undervalued.
Does ImmunoPrecise Antibodies pay dividends?
ImmunoPrecise Antibodies does not currently pay dividends.
What is ImmunoPrecise Antibodies’s EPS estimate?
ImmunoPrecise Antibodies’s EPS estimate is -$0.06.
How many shares outstanding does ImmunoPrecise Antibodies have?
ImmunoPrecise Antibodies has 31,062,270 shares outstanding.
What happened to ImmunoPrecise Antibodies’s price movement after its last earnings report?
ImmunoPrecise Antibodies reported an EPS of -$0.062 in its last earnings report, beating expectations of -$0.066. Following the earnings report the stock price went down -4.762%.
Which hedge fund is a major shareholder of ImmunoPrecise Antibodies?
Currently, no hedge funds are holding shares in IPA
---
ImmunoPrecise Antibodies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.00 (1149.69% Upside)
$5.00 (1149.69% Upside)
Insider Transactions
Bought Shares
Worth $201.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.9%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.37%
12-Months-Change
Fundamentals
Return on Equity
-66.50%
Trailing 12-Months
Asset Growth
-21.02%
Trailing 12-Months
Company Description
ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. engages in the provision of integrated antibody solutions. It services include human monoclonals, hybridoma development, rabbit monoclonals, b-cell select, phage display, cryostorage, hybridoma sequencing, antibody generation, anti-body purification, polyclonal production, and peptide production. The company was founded by Robert Beecroft in 1989 and is headquartered in Victoria, Canada.
---
IPA Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlights several significant strategic advancements, particularly in AI-driven drug discovery and cost efficiency initiatives. However, financial metrics like flat year-over-year revenue and increased operating expenses present challenges. The sentiment is balanced with strong growth potential through strategic moves and partnerships, but tempered by current financial constraints and market recovery challenges.Read More>---
IPA Stock 12 Month Forecast
Average Price Target
$5.00
▲(1149.69% Upside)
Technical Analysis
Best Analysts Covering IPA
1 Year
1 Year Success Rate
1/9 ratings generated profit
1 Year Average Return
-51.32%
reiterated a buy rating 11 days ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -51.32% per trade.
---